UBS AM’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Hold
12,784
﹤0.01% 2656
2026
Q1
$288K Buy
12,784
+10,340
+423% +$238K ﹤0.01% 2666
2025
Q4
$58.2K Buy
+2,444
New +$60.8K ﹤0.01% 2596
2019
Q4
Sell
-2,882
Closed -$96.8K 2634
2019
Q3
$96.8K Sell
2,882
-114
-4% -$4.04K ﹤0.01% 2666
2019
Q2
$118K Hold
2,996
﹤0.01% 2626
2019
Q1
$121K Sell
2,996
-123
-4% -$4.58K ﹤0.01% 2551
2018
Q4
$101K Sell
3,119
-687
-18% -$27.7K ﹤0.01% 2514
2018
Q3
$196K Buy
3,806
+34
+0.9% +$1.7K ﹤0.01% 2455
2018
Q2
$190K Buy
3,772
+1,008
+36% +$51.1K ﹤0.01% 2487
2018
Q1
$141K Buy
2,764
+407
+17% +$21.7K ﹤0.01% 2431
2017
Q4
$124K Hold
2,357
﹤0.01% 2379
2017
Q3
$115K Hold
2,357
﹤0.01% 2351
2017
Q2
$114K Buy
2,357
+81
+4% +$3.73K ﹤0.01% 2328
2017
Q1
$95.9K Sell
2,276
-409
-15% -$16.9K ﹤0.01% 2304
2016
Q4
$1.13M Buy
+2,685
New +$110K ﹤0.01% 1509
2014
Q1
Sell
-5,633
Closed -$200K 2587
2013
Q4
$200K Sell
5,633
-696
-11% -$23.3K ﹤0.01% 2371
2013
Q3
$205K Sell
6,329
-4,225
-40% -$138K ﹤0.01% 2314
2013
Q2
$372K Buy
+10,554
New +$367K ﹤0.01% 1859

Other funds holding FMS

UBS AM's FMS Position: Q2 2026 in Review

UBS AM held its Fresenius Medical Care (FMS) position steady in Q2 2026 at 12,784 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

UBS AM first reported a position in FMS in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.13M in Q4 2016. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • UBS AM held 12,784 shares of Fresenius Medical Care worth $289K as of Q2 2026.
  • UBS AM left its Fresenius Medical Care share count unchanged in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2656 holding.
  • UBS AM first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 18 quarters since.
  • UBS AM's Fresenius Medical Care position peaked at $1.13M in Q4 2016.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.